Andogel® (Testosterone gel) 1%: Unimed Pharmaceuticals, a wholly-owned subsidiary of Solvay Pharmaceuticals, Inc, has been informed by generic player Perrigo Israel Pharmaceuticals, Ltd. (Perrigo) that it has fiiled an Abbreviated New Drug Application (ANDA) with a Paragraph IV certification to the U.S. Food and Drug Administration, seeking the approval of a generic version of Andogel® (testosterone gel) 1% CIII in the United States.
Press release from Solvay Here
OxyContin® (oxycodone HCl controlled-release): Generic player KV Pharma announced that it has entered into a settlement agreement with innovator Purdue Pharma w.r.t the patent infringement lawsuit between the two companies.
Press release from KV pharma Here
Omeprazole Mg 20.6 mg capsule (OTC): Dr. Reddy’s Laboratories announced that the U.S. Food and Drug Administration has granted approval of the Company’s Abbreviated New Drug Application (ANDA) for Omeprazole Mg 20.6 mg capsule (OTC).
Omeprazole Mg 20.6 mg capsule (OTC): Dr. Reddy’s Laboratories announced that the U.S. Food and Drug Administration has granted approval of the Company’s Abbreviated New Drug Application (ANDA) for Omeprazole Mg 20.6 mg capsule (OTC).
Press release fom Dr. Reddy Here
Calcitonin-salmon (Miacalcin ) nasal spray: Par Pharmaceutical has began shipping calcitonin-salmon nasal spray to the trade. Calcitonin-salmon nasal spray is a generic version of Novartis' Miacalcin(R).
Calcitonin-salmon (Miacalcin ) nasal spray: Par Pharmaceutical has began shipping calcitonin-salmon nasal spray to the trade. Calcitonin-salmon nasal spray is a generic version of Novartis' Miacalcin(R).
Press release from Par Pharma Here
Risperidone ODT 0.25 mg, 3 mg and 4 mg Tablets ( RISPERDAL® M-TAB): Par Pharmaceutical has began shipping 0.25 mg, 3 mg and 4 mg strengths of Risperidone ODT to the trade. Probably, Par is first Para IV filer for this product.
Press release from Par Pharma Here
No comments:
Post a Comment